Entera Bio Ltd. SEC filings ENTX
Entera Bio Ltd. has 418 filings in SEC EDGAR's recent list, going back to May 1, 2015. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Jun 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| DEF 14A | Proxy statement | Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 23, 2026 | Sep 23, 2026 |
| EFFECT | Filing | Aug 28, 2026 | — |
| 424B3 | Prospectus | Aug 28, 2026 | — |
| S-3 | Shelf registration | Aug 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2026 | Aug 18, 2026 |
| D | Filing | Aug 12, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jul 28, 2026 | Jul 26, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jul 16, 2026 | Jul 14, 2026 |
| DEFA14A | Additional proxy material | Jun 3, 2026 | — |
| ARS | Annual report to shareholders | Jun 3, 2026 | Jun 3, 2026 |
| DEF 14A | Proxy statement | Jun 3, 2026 | Jun 3, 2026 |
| EFFECT | Filing | May 15, 2026 | — |
| 424B3 | Prospectus | May 15, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 14, 2026 | May 14, 2026 |
| CORRESP | Letter to the SEC | May 13, 2026 | — |
| UPLOAD | Letter from the SEC | May 12, 2026 | — |
| S-3 | Shelf registration | May 8, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2026 | May 8, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 3, 2026 | Apr 1, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 9, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Feb 4, 2026 | Jan 29, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 18, 2025 | Jul 16, 2025 |
| EFFECT | Filing | Jun 6, 2025 | — |
| 424B3 | Prospectus | Jun 6, 2025 | — |
| DEFA14A | Additional proxy material | Jun 5, 2025 | — |
| ARS | Annual report to shareholders | Jun 5, 2025 | May 29, 2025 |
| DEF 14A | Proxy statement | Jun 5, 2025 | Jun 5, 2025 |
| CORRESP | Letter to the SEC | Jun 4, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2025 | — |
| S-8 | Employee stock plan registration | May 30, 2025 | — |
| S-3 | Shelf registration | May 30, 2025 | — |
| UPLOAD | Letter from the SEC | May 23, 2025 | — |
| CORRESP | Letter to the SEC | May 20, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2025 | May 9, 2025 |
| UPLOAD | Letter from the SEC | May 6, 2025 | — |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 17, 2025 | Mar 16, 2025 |
| 8-K | Current report | Jan 10, 2025 | Jan 10, 2025 |
| 424B5 | Prospectus supplement | Jan 10, 2025 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
Dec 20, 2024 | Jul 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2024 | Nov 8, 2024 |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 2, 2024 | Jul 31, 2024 |
| DEFA14A | Additional proxy material | Jun 20, 2024 | — |
| ARS | Annual report to shareholders | Jun 20, 2024 | Jun 20, 2024 |
| DEF 14A | Proxy statement | Jun 20, 2024 | Jun 20, 2024 |
| PRE 14A | Preliminary proxy statement | May 29, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2024 | May 10, 2024 |
| S-8 | Employee stock plan registration | Mar 8, 2024 | — |
| 10-K | Annual report | Mar 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 8, 2024 | Mar 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 424B3 | Prospectus | Feb 15, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| S-3/A | Filing | Feb 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2024 | Feb 2, 2024 |
| S-3 | Shelf registration | Feb 2, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 3, 2024 | Jan 3, 2024 |
| D | Filing | Jan 2, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 26, 2023 | Dec 20, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 13, 2023 | Sep 13, 2023 |
| ARS | Annual report to shareholders | Aug 16, 2023 | Aug 15, 2023 |
| DEF 14A | Proxy statement | Aug 15, 2023 | Aug 15, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2023 | Aug 11, 2023 |
| PRER14A | Filing | Jul 28, 2023 | — |
| 8-K |
Current report
Listing notice
|
Jun 30, 2023 | Jun 29, 2023 |
| 25-NSE/A | Filing | Jun 29, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 27, 2023 | Jun 27, 2023 |
| PRE 14A | Preliminary proxy statement | Jun 23, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2023 | Jun 4, 2023 |
| S-8 | Employee stock plan registration | Jun 2, 2023 | — |
| 10-Q | Quarterly report | May 5, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2023 | May 5, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 23, 2022 | Nov 21, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Other events
|
Oct 6, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Sep 9, 2022 | Sep 7, 2022 |
| 424B5 | Prospectus supplement | Sep 2, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 2, 2022 | Sep 2, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 1, 2022 | Aug 1, 2022 |
| DEF 14A | Proxy statement | Jul 29, 2022 | Jul 29, 2022 |
| PRE 14A | Preliminary proxy statement | Jul 19, 2022 | Jul 19, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 18, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 17, 2022 | Jun 15, 2022 |
| 424B3 | Prospectus | Jun 10, 2022 | — |
| 424B3 | Prospectus | Jun 10, 2022 | — |
| EFFECT | Filing | Jun 9, 2022 | — |
| EFFECT | Filing | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | Jun 7, 2022 | — |
| CORRESP | Letter to the SEC | Jun 7, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2022 | — |
| S-3 | Shelf registration | May 27, 2022 | — |
| S-3 | Shelf registration | May 27, 2022 | — |
| 8-K |
Current report
Material agreement
|
May 27, 2022 | May 27, 2022 |
| 8-K |
Current report
Officer or director change
|
May 16, 2022 | May 11, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| 10-K/A | Amended annual report | Apr 29, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 8, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 8, 2022 | Mar 8, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2021 | Nov 10, 2021 |
| 6-K | Current report (foreign issuer) | Nov 10, 2021 | Nov 10, 2021 |
| 6-K | Current report (foreign issuer) | Oct 28, 2021 | Oct 28, 2021 |
| 6-K | Current report (foreign issuer) | Oct 14, 2021 | Oct 14, 2021 |
| 6-K | Current report (foreign issuer) | Oct 6, 2021 | Oct 6, 2021 |
| 6-K | Current report (foreign issuer) | Sep 1, 2021 | Sep 1, 2021 |
| 6-K | Current report (foreign issuer) | Aug 27, 2021 | Aug 28, 2021 |
| 6-K | Current report (foreign issuer) | Aug 23, 2021 | Aug 23, 2021 |
| 6-K | Current report (foreign issuer) | Aug 23, 2021 | Aug 23, 2021 |
| 6-K | Current report (foreign issuer) | Aug 16, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Aug 16, 2021 | Aug 16, 2021 |
| 6-K | Current report (foreign issuer) | Aug 2, 2021 | Aug 2, 2021 |
| 6-K | Current report (foreign issuer) | Jun 23, 2021 | Jun 23, 2021 |
| 6-K | Current report (foreign issuer) | Jun 22, 2021 | Jun 22, 2021 |
| 6-K | Current report (foreign issuer) | Jun 17, 2021 | Jun 17, 2021 |
| 6-K | Current report (foreign issuer) | May 20, 2021 | May 20, 2021 |
| 6-K | Current report (foreign issuer) | May 20, 2021 | May 20, 2021 |
| 424B5 | Prospectus supplement | May 7, 2021 | — |
| 6-K | Current report (foreign issuer) | Apr 20, 2021 | Apr 20, 2021 |
| 6-K | Current report (foreign issuer) | Apr 15, 2021 | Apr 15, 2021 |
| 6-K | Current report (foreign issuer) | Apr 6, 2021 | Apr 6, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 18, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 18, 2021 | Mar 18, 2021 |
| 6-K | Current report (foreign issuer) | Mar 11, 2021 | Mar 11, 2021 |
| 6-K | Current report (foreign issuer) | Mar 3, 2021 | Mar 3, 2021 |
| 6-K | Current report (foreign issuer) | Feb 25, 2021 | Feb 25, 2021 |
| 6-K | Current report (foreign issuer) | Feb 8, 2021 | Feb 8, 2021 |
| 6-K | Current report (foreign issuer) | Jan 11, 2021 | Jan 11, 2021 |
| 6-K | Current report (foreign issuer) | Jan 11, 2021 | Jan 11, 2021 |
| 6-K | Current report (foreign issuer) | Dec 10, 2020 | Dec 10, 2020 |
| 6-K | Current report (foreign issuer) | Nov 30, 2020 | Nov 30, 2020 |
| 6-K | Current report (foreign issuer) | Nov 19, 2020 | Nov 19, 2020 |
| 6-K | Current report (foreign issuer) | Nov 19, 2020 | Nov 19, 2020 |
| 6-K | Current report (foreign issuer) | Nov 9, 2020 | Nov 9, 2020 |
| 6-K | Current report (foreign issuer) | Aug 20, 2020 | Jun 30, 2020 |
| 6-K | Current report (foreign issuer) | Aug 20, 2020 | Aug 20, 2020 |
| 6-K | Current report (foreign issuer) | Aug 17, 2020 | Aug 17, 2020 |
| 6-K | Current report (foreign issuer) | Aug 10, 2020 | Aug 10, 2020 |
| 6-K | Current report (foreign issuer) | Aug 5, 2020 | Aug 5, 2020 |
| EFFECT | Filing | Jul 22, 2020 | — |
| 6-K | Current report (foreign issuer) | Jul 22, 2020 | Jul 22, 2020 |
| CORRESP | Letter to the SEC | Jul 20, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 13, 2020 | — |
| 6-K | Current report (foreign issuer) | Jul 7, 2020 | Jul 7, 2020 |
| 6-K | Current report (foreign issuer) | Jun 26, 2020 | Jun 26, 2020 |
| EFFECT | Filing | Jun 24, 2020 | — |
| CORRESP | Letter to the SEC | Jun 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 5, 2020 | — |
| 6-K | Current report (foreign issuer) | May 21, 2020 | May 21, 2020 |
| 6-K | Current report (foreign issuer) | May 21, 2020 | May 21, 2020 |
| 6-K | Current report (foreign issuer) | May 13, 2020 | May 13, 2020 |
| 20-F | Annual report (foreign issuer) | Mar 26, 2020 | Dec 31, 2019 |
| 6-K | Current report (foreign issuer) | Mar 26, 2020 | Mar 26, 2020 |
| 6-K | Current report (foreign issuer) | Feb 19, 2020 | Feb 19, 2020 |
| 6-K | Current report (foreign issuer) | Jan 14, 2020 | Jan 14, 2020 |
| D | Filing | Dec 26, 2019 | — |
| 6-K | Current report (foreign issuer) | Dec 18, 2019 | Dec 18, 2019 |
| 6-K | Current report (foreign issuer) | Dec 11, 2019 | Dec 11, 2019 |
| 6-K | Current report (foreign issuer) | Nov 21, 2019 | Nov 21, 2019 |
| 6-K | Current report (foreign issuer) | Nov 21, 2019 | Nov 21, 2019 |
| 6-K | Current report (foreign issuer) | Oct 10, 2019 | Oct 10, 2019 |
| 6-K | Current report (foreign issuer) | Sep 23, 2019 | Sep 23, 2019 |
| 6-K | Current report (foreign issuer) | Aug 29, 2019 | Aug 29, 2019 |
| 6-K | Current report (foreign issuer) | Aug 20, 2019 | Aug 20, 2019 |
| 6-K | Current report (foreign issuer) | Aug 5, 2019 | Aug 5, 2019 |
| 6-K | Current report (foreign issuer) | Jul 2, 2019 | Jul 2, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ENTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Jerusalem
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1638097
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.